Quantex Laboratories has completed the expansion of its GMP analytical laboratory with its relocation to a larger, state of the art facility at 3000 Eastpark Boulevard in Cranbury, New Jersey. With the new facility nearly four times the size of Quantex Laboratories’ previous site, the company is also adding microbiological testing capabilities later in the year to its contract laboratory and analytical testing CRO services.
The planned expansion was moved forward after the company’s previous location sustained damage from Hurricane Sandy. Quantex is now located in the former Pharmacopeia Drug Discovery headquarters facility.
“The new facility enables us to offer our clients a broader range of fully compliant GMP and GLP services,” said James Menoutis, President and CEO of Quantex. “We’ve also made a significant investment in upgrading our instrumentation to service the growing needs of the bio/pharmaceutical, personal care products and cosmetics markets with expanded capabilities”
“Our relocation to a New Jersey facility is an indication of our belief in the state’s biotech, pharmaceutical and commercial strength,” said Menoutis. “It’s also a testament to the support provided by the New Jersey Business Action Center both during and after the storm.”
The Christie Administration’s commitment to innovation and discovery is strong,” said Lt. Governor Kim Guadagno. “We’re proud to have companies like Quantex Laboratories expand their operations here in the Garden State, further enhancing New Jersey’s tradition as a leader in life sciences.”